Lifetech MFO Post-Market Clinical Follow-Up Study
Learn more about:
Related Clinical Trial
Regional Anesthesia Following Pediatric Cardiac Surgery
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
The Effect of Transcatheter VSD Closure on Children’s Appetite, Hormones and Growth
The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters
Improving Care for Children With Congenital Heart Disease.
Lifetech MFO Post-Market Clinical Follow-Up Study
Measures to Lower the Stress Response in Pediatric Cardiac Surgery
Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
Optical Tissue Identification for Myocardial Architecture
Cardiac Function After Transcatheter VSD Closure
The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension
A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure
Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder – Post Approval Study
The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
Optimal Timing for Repair of Left to Right Shunt Lesions
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow
Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect
Longterm Outcome After Ventricular Septal Defect Closure
Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER
Hybrid Closure of Congenital Heart Disease
Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects